Thu, Oct 23, 2014, 6:10 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Star Bulk Carriers Corp. Message Board

canstic1 226 posts  |  Last Activity: 8 hours ago Member since: Jul 13, 2001
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Under the terms of the distribution agreement, Terumo Europe NV will have the exclusive right to market MicroThermX® in 100 countries in Europe, Western Asia, and Northern Africa. The potential market size for MicroThermX® in these countries is estimated to be in excess of $1 billion in annual sales. This agreement validates the large market opportunity for MicroThermX® ablation products and is expected to drive market adoption for the MicroThermX® as a leading ablation therapy system. Strategically, MicroThermX® will benefit from Terumo Europe NV’s extensive market reach, focus on interventional oncology, and well-established relationships with key interventional oncology opinion leaders throughout Europe.

    "Our distribution agreement with Terumo Europe NV is the result of a collaborative effort between BSD Medical and Terumo. Importantly, it represents one of the most significant milestones in BSD’s corporate history," said Harold Wolcott, BSD President and CEO. "Revenues from our agreement with Terumo Europe NV should commence by the end of the third quarter of our fiscal year 2013 and are expected to make a substantial contribution to our overall revenue over the next few years. Longer term, we expect this agreement will make a strong contribution toward our objective of achieving profitability."

  • If you don't think Terumo got into this deal with BSDM to move hundreds of millions of dollars worth of BSDM product then you have rocks in your head.

    About Terumo Corporation

    A world leader in state-of-the-art medical devices and interventional oncology, Tokyo-based Terumo Corporation (TYO: JP:4543) reported 2013 sales of nearly $5 billion and has a market cap in excess of $8 billion. Through the sale and promotion of a high quality line of devices used for tumor embolization, the closing or blocking of blood vessels, Terumo Europe NV has established itself as a pioneer in the field of interventional oncology.

  • There is indeed a multi year agreement in place with Terumo, a multi billion dollar medical device distributor. There is a "secrecy clause" for lack of a better word, which prohibits BSDM from disclosing terms of the agreement, or specific sales numbers. This is in place in order to allow Terumo an opportunity to ramp up sales without giving away any strategic information to the competition.

    Terumo has invested substantial amounts into the launch of MicrothermX AROUND THE GLOBE INTO 100 COUNTRIES. Probably millions, as was in their agreement. They are presenting at all the conferences and showing/training on the product.

    Sales are being made virtually everyday, either of new systems or from re-orders of the replaceable single use antennas. All this information is in the recent press releases, and it's all TRUE.

    Korn Ferry, a very well know high end executive search firm has presented the board with several candidates for the CEO position and they are all being interviewed and vetted.

    Business continues unimpeded at BSDM, and Butch Wolcott is still very much leading the company, and will remain on the Board after his replacement is found. His departure is in no way linked to performance at the company. It was pointed out that he was instrumental in securing the Terumo agreement and remains instrumental for future agreements CURRENTLY being negotiated.

    The business continues, expansion continues, there is plenty of cash in the bank, the company is operating on all cylinders.

    Anything else said here or on any other message board is a blatant lie, most likely spread by the competition in an attempt to strengthen their position at the bargaining table, with regards to alliances now being discussed.

    Call or email the company and they will address your questions directly.

    Terumo will never allow BSDM to go under or be sold outright without their approval. They have an enormous stake in them due to the fact that they have invested millions of dollars and thousands of man hours to educate and teach the market about MicroThermX such that they can SELL SELL SELL for years to come.

    MicrothermX has a cash cow "razorblade" business model. The antennas sell for 2-3 thousand dollars each and up to three can be used in each procedure. THEY ARE SINGLE USE. DISPOSABLE.

    Simple math tells you that if Terumo places 100 MicroThermX systems and sells just 20 antennas a month to each unit holder, then there will be 4-5 million dollars in sales EVERY MONTH.

    100 x 20 x $2,000 = $4,000,000 a month and that's just a TINY example...... it will grow to significantly more!

    Anyone buying a MicroThermX will want to put it to use and keep it in use. They will not buy one and only do "a few" procedures in a month. They will do MANY MANY MANY, to recoup the investment and MAKE MONEY. Medicine is a business.

    For God's sake do the math and see the numbers. Microwave ablation is overtaking RFA as the number one method for tumor ablation due to it's superiority and efficacy and safety on nearly all counts. ALL studies show this.

    Don't believe the lies printed on these message boards.

    L@@K for yourselves at the evidence, and call the company !!!!!!!!!!

    AND I HAVE NOT EVEN TOUCHED ON THE HYPERTHERMIA BUSINESS and all the contracts in place in ASIA!

  • Terumo Europe NV Showcases BSD Medical’s MicroThermX® at CIRSE - Sept 22
    SALT LAKE CITY--(BUSINESS WIRE)--

    BSD Medical Corporation (BSDM) announced today that Terumo Europe NV (Terumo), a wholly owned subsidy of Terumo Corporation, successfully showcased BSD’s MicroThermX®Microwave Ablation System (MicroThermX) at the annual Cardiovascular and Interventional Radiological Society of Europe (CIRSE) conference, the world’s largest and most prestigious conference in the field of minimally invasive image-guided therapies.

    Terumo hosted hands-on workshops which provided physicians the opportunity to see firsthand how the MicroThermX is applicable to treating diseased soft tissue (tumors). In addition, Professors P. Chevailier (Nice/FR) and J. –Y Gaubert (Marseille/FR) presented a study on the benefits of the MicroThermX system titled, “In vivo experimental evaluation of ablation volumes obtained by microwave in the lung and liver with MicroThermX.” Finally, Terumo sponsored a presentation on the “Clinical Benefits of Multiple Antenna Application,” in which BSD’s MicroThermX system was featured.

    “At CIRSE, we successfully showcased the MicroThermX and received tremendous feedback from the numerous physicians, administrators and clinical personnel in attendance,” said Sam Maravich, Vice President of International Sales and Marketing of BSD Medical. “We continue to be extremely pleased with Terumo’s implementation of its well-planned marketing strategy for the MicroThermX. Terumo’s strong focus on MicroThermX at CIRSE shows both their clinical and financial commitment to our product. We continue to see solid sales traction in Western Europe, and conferences like CIRSE will benefit Terumo's expansion into Eastern European, African and Middle Eastern countries.”

    Celebrating thirty years of innovation, education and intervention, CIRSE welcomed thousands of physicians, hospital administrators, decision makers and other delegates from over 90 countries. CIRSE was held in Glasgow, UK, on September 13-17, 2014.

    About Terumo Corporation

    A world leader in state-of-the-art medical devices and interventional oncology, Tokyo-based Terumo Corporation (TYO: JP:4543) reported 2013 sales of nearly $5 billion and has a market cap in excess of $8 billion. Through the sale and promotion of a high quality line of devices used for tumor embolization, the closing or blocking of blood vessels, Terumo Europe NV has established itself as a pioneer in the field of interventional oncology.

    About the MicroThermX Microwave Ablation System

    The MicroThermX is a compact, mobile, state-of-the-art, proprietary system that includes a microwave generator, single-patient-use disposable antennas, and a thermistor-based temperature monitoring system. The innovative design of the MicroThermX is the first of its kind that allows delivery of higher power levels using a single generator.

    The MicroThermX utilizes innovative synchronous phased array technology that was developed and patented by MicroThermX BSD to provide a wide range of uniform zones of ablation. The MicroThermX includes innovative, high-end disposables (SynchroWave antennas) that are used in each ablation treatment and will provide a significant ongoing revenue stream.

    The soft tissue (tumor) ablation world market potential is estimated to exceed $2.3 billion. The U.S. Food and Drug Administration (FDA) has granted the Company a 510(k) clearance to market the MicroThermXfor ablation of soft tissue. BSD has also received CE Marking for the MicroThermX System, which allows BSD to market the MicroThermX in Europe. CE Marking is also recognized in many countries outside of the EU, providing BSD the ability to market the MicroThermX to a number of international markets.

  • Wow! Just look at all the NEW basher ID's that have suddenly appeared on this tiny little insignificant message board. A 50 cent stock, market cap 20 million $....why? Where did all these people come from? the short position is negligible.....so where did all these new ID bashers and haters come from? Why are they here? Are they all the same person? Or maybe they all WORK FOR THE SAME PERSON/COMPANY.

    Most likely they all work together in unison to destroy value so that their employer can BUY THE COMPANY, or STRIKE A DISTRIBUTION DEAL, or BUY A DIVISION (such as hyperthermia) much much cheaper, on better terms. They want to make this company look as bad as possible, so that they can buy it cheaper.

    This message board should be empty of bashers by now. Certainly there should not be new ones appearing. The company has too many positives going for it for new shorts to start at 50 cents. Not happening.

    No, the opposite is happening. These people are trying to BUY and there is no stock available. The volume is basically nothing, and any attempt to buy size sends BSDM running up, so they need to scare some people into selling.

    Think about it!

    Who are all these new bashers and why did they appear NOW?

    Don't sell your stock to them. Ignore them all. You know the BSDM story by now. Get long and get off the message boards. Sleep easy. Good things are happening at BSDM. The stock will rise again.

    Cheers.

  • canstic1 canstic1 Oct 22, 2014 10:47 AM Flag

    BSD Medical (BSDM) MicroThermX as seen on TERUMO EUROPE global distributor website


    http://www.terumo-europe.com/endovascular/products/microthermx-microwave-ablation-system.php

  • canstic1 canstic1 Oct 22, 2014 10:31 AM Flag

    Terumo Europe NV Showcases BSD Medical’s MicroThermX® at CIRSE - Sept 22
    SALT LAKE CITY--(BUSINESS WIRE)--

    BSD Medical Corporation (BSDM) announced today that Terumo Europe NV (Terumo), a wholly owned subsidy of Terumo Corporation, successfully showcased BSD’s MicroThermX®Microwave Ablation System (MicroThermX) at the annual Cardiovascular and Interventional Radiological Society of Europe (CIRSE) conference, the world’s largest and most prestigious conference in the field of minimally invasive image-guided therapies.

    Terumo hosted hands-on workshops which provided physicians the opportunity to see firsthand how the MicroThermX is applicable to treating diseased soft tissue (tumors). In addition, Professors P. Chevailier (Nice/FR) and J. –Y Gaubert (Marseille/FR) presented a study on the benefits of the MicroThermX system titled, “In vivo experimental evaluation of ablation volumes obtained by microwave in the lung and liver with MicroThermX.” Finally, Terumo sponsored a presentation on the “Clinical Benefits of Multiple Antenna Application,” in which BSD’s MicroThermX system was featured.

    “At CIRSE, we successfully showcased the MicroThermX and received tremendous feedback from the numerous physicians, administrators and clinical personnel in attendance,” said Sam Maravich, Vice President of International Sales and Marketing of BSD Medical. “We continue to be extremely pleased with Terumo’s implementation of its well-planned marketing strategy for the MicroThermX. Terumo’s strong focus on MicroThermX at CIRSE shows both their clinical and financial commitment to our product. We continue to see solid sales traction in Western Europe, and conferences like CIRSE will benefit Terumo's expansion into Eastern European, African and Middle Eastern countries.”

    Celebrating thirty years of innovation, education and intervention, CIRSE welcomed thousands of physicians, hospital administrators, decision makers and other delegates from over 90 countries. CIRSE was held in Glasgow, UK, on September 13-17, 2014.

    About Terumo Corporation

    A world leader in state-of-the-art medical devices and interventional oncology, Tokyo-based Terumo Corporation (TYO: JP:4543) reported 2013 sales of nearly $5 billion and has a market cap in excess of $8 billion. Through the sale and promotion of a high quality line of devices used for tumor embolization, the closing or blocking of blood vessels, Terumo Europe NV has established itself as a pioneer in the field of interventional oncology.

    About the MicroThermX Microwave Ablation System

    The MicroThermX is a compact, mobile, state-of-the-art, proprietary system that includes a microwave generator, single-patient-use disposable antennas, and a thermistor-based temperature monitoring system. The innovative design of the MicroThermX is the first of its kind that allows delivery of higher power levels using a single generator.

    The MicroThermX utilizes innovative synchronous phased array technology that was developed and patented by MicroThermX BSD to provide a wide range of uniform zones of ablation. The MicroThermX includes innovative, high-end disposables (SynchroWave antennas) that are used in each ablation treatment and will provide a significant ongoing revenue stream.

    The soft tissue (tumor) ablation world market potential is estimated to exceed $2.3 billion. The U.S. Food and Drug Administration (FDA) has granted the Company a 510(k) clearance to market the MicroThermXfor ablation of soft tissue. BSD has also received CE Marking for the MicroThermX System, which allows BSD to market the MicroThermX in Europe. CE Marking is also recognized in many countries outside of the EU, providing BSD the ability to market the MicroThermX to a number of international markets.

  • canstic1 canstic1 Oct 22, 2014 10:25 AM Flag

    There is indeed a multi year agreement in place with Terumo, a multi billion dollar medical device distributor. There is a "secrecy clause" for lack of a better word, which prohibits BSDM from disclosing terms of the agreement, or specific sales numbers. This is in place in order to allow Terumo an opportunity to ramp up sales without giving away any strategic information to the competition.

    Terumo has invested substantial amounts into the launch of MicrothermX AROUND THE GLOBE INTO 100 COUNTRIES. Probably millions, as was in their agreement. They are presenting at all the conferences and showing/training on the product.

    Sales are being made virtually everyday, either of new systems or from re-orders of the replaceable single use antennas. All this information is in the recent press releases, and it's all TRUE.

    Korn Ferry, a very well know high end executive search firm has presented the board with several candidates for the CEO position and they are all being interviewed and vetted.

    Business continues unimpeded at BSDM, and Butch Wolcott is still very much leading the company, and will remain on the Board after his replacement is found. His departure is in no way linked to performance at the company. It was pointed out that he was instrumental in securing the Terumo agreement and remains instrumental for future agreements CURRENTLY being negotiated.

    The business continues, expansion continues, there is plenty of cash in the bank, the company is operating on all cylinders.

    Anything else said here or on any other message board is a blatant lie, most likely spread by the competition in an attempt to strengthen their position at the bargaining table, with regards to alliances now being discussed.

    Call or email the company and they will address your questions directly.

    Terumo will never allow BSDM to go under or be sold outright without their approval. They have an enormous stake in them due to the fact that they have invested millions of dollars and thousands of man hours to educate and teach the market about MicroThermX such that they can SELL SELL SELL for years to come.

    MicrothermX has a cash cow "razorblade" business model. The antennas sell for 2-3 thousand dollars each and up to three can be used in each procedure. THEY ARE SINGLE USE. DISPOSABLE.

    Simple math tells you that if Terumo places 100 MicroThermX systems and sells just 20 antennas a month to each unit holder, then there will be 4-5 million dollars in sales EVERY MONTH.

    100 x 20 x $2,000 = $4,000,000 a month and that's just a TINY example...... it will grow to significantly more!

    Anyone buying a MicroThermX will want to put it to use and keep it in use. They will not buy one and only do "a few" procedures in a month. They will do MANY MANY MANY, to recoup the investment and MAKE MONEY. Medicine is a business.

    For God's sake do the math and see the numbers. Microwave ablation is overtaking RFA as the number one method for tumor ablation due to it's superiority and efficacy and safety on nearly all counts. ALL studies show this.

    Don't believe the lies printed on these message boards.

    L@@K for yourselves at the evidence, and call the company !!!!!!!!!!

    AND I HAVE NOT EVEN TOUCHED ON THE HYPERTHERMIA BUSINESS and all the contracts in place in ASIA!

  • canstic1 canstic1 Oct 22, 2014 10:17 AM Flag

    The deal with Orientech China, which is now approved by the China FDA is for sale of eight (8) BSD-200's per year at a MINIMUM. They will most likely buy more. The deal to Taiwan calls for sale of 5 units per year MINIMUM, and they will most likely buy more. South Korea has a deal for anothe 5 per year, but the approval in SK is still pending.

    We are now in the Q1 of fiscal year 2015 for BSDM. AT A MINIMUM, for this new fiscal year there will be 13 BSD-2000's sold, guaranteed to China and Taiwan. BSDM has never sold 13 bsd-200's in a single year , ever!

    These machines sell for $500,000 to over $1 million depending on how they are outfitted. That means at a minimum, and I stress MINIMUM, there will be $6.5 million in sales of BSD-2000's in fiscal year 2015.

    ADD in the sales of MicroThermX and replaceable antennas, and the MINIMUM sales I can possibly see occuring in fiscal 2015 is at least $10 million. BSDM has never had $10,000,000 in sales EVER

    And the stock is 50 cents? The historical low?

    What about GROWTH IN SALES? Factor that in? More likely BSDM will be pushing 20 million in sales than 10 million in fiscal 2015.

    THINK PEOPLE. You are being handed a golden opportunity. Don't blow it.

  • canstic1 canstic1 Oct 21, 2014 10:59 PM Flag

    investednotinterested = wonderfulworldofjulestoo....another of his multiple ID's...he gives it away everytime with his choice of language. ........"cretin" ....caught you again. Give it up, loser.

  • canstic1 canstic1 Oct 21, 2014 8:00 PM Flag

    fantastic due diligence and research on BSDM, with many links, found at Investor Village posts number 7189 and 7190.

  • canstic1 canstic1 Oct 21, 2014 6:33 PM Flag

    The deal with Orientech China, which is now approved by the China FDA is for sale of eight (8) BSD-200's per year at a MINIMUM. They will most likely buy more. The deal to Taiwan calls for sale of 5 units per year MINIMUM, and they will most likely buy more. South Korea has a deal for anothe 5 per year, but the approval in SK is still pending.

    We are now in the Q1 of fiscal year 2015 for BSDM. AT A MINIMUM, for this new fiscal year there will be 13 BSD-2000's sold, guaranteed to China and Taiwan. BSDM has never sold 13 bsd-200's in a single year , ever!

    These machines sell for $500,000 to over $1 million depending on how they are outfitted. That means at a minimum, and I stress MINIMUM, there will be $6.5 million in sales of BSD-2000's in fiscal year 2015.

    ADD in the sales of MicroThermX and replaceable antennas, and the MINIMUM sales I can possibly see occuring in fiscal 2015 is at least $10 million. BSDM has never had $10,000,000 in sales EVER

    And the stock is 50 cents? The historical low?

    What about GROWTH IN SALES? Factor that in? More likely BSDM will be pushing 20 million in sales than 10 million in fiscal 2015.

    THINK PEOPLE. You are being handed a golden opportunity. Don't blow it.

  • canstic1 canstic1 Oct 21, 2014 6:32 PM Flag

    There is indeed a multi year agreement in place with Terumo, a multi billion dollar medical device distributor. There is a "secrecy clause" for lack of a better word, which prohibits BSDM from disclosing terms of the agreement, or specific sales numbers. This is in place in order to allow Terumo an opportunity to ramp up sales without giving away any strategic information to the competition.

    Terumo has invested substantial amounts into the launch of MicrothermX AROUND THE GLOBE INTO 100 COUNTRIES. Probably millions, as was in their agreement. They are presenting at all the conferences and showing/training on the product.

    Sales are being made virtually everyday, either of new systems or from re-orders of the replaceable single use antennas. All this information is in the recent press releases, and it's all TRUE.

    Korn Ferry, a very well know high end executive search firm has presented the board with several candidates for the CEO position and they are all being interviewed and vetted.

    Business continues unimpeded at BSDM, and Butch Wolcott is still very much leading the company, and will remain on the Board after his replacement is found. His departure is in no way linked to performance at the company. It was pointed out that he was instrumental in securing the Terumo agreement and remains instrumental for future agreements CURRENTLY being negotiated.

    The business continues, expansion continues, there is plenty of cash in the bank, the company is operating on all cylinders.

    Anything else said here or on any other message board is a blatant lie, most likely spread by the competition in an attempt to strengthen their position at the bargaining table, with regards to alliances now being discussed.

    Call or email the company and they will address your questions directly.

    Terumo will never allow BSDM to go under or be sold outright without their approval. They have an enormous stake in them due to the fact that they have invested millions of dollars and thousands of man hours to educate and teach the market about MicroThermX such that they can SELL SELL SELL for years to come.

    MicrothermX has a cash cow "razorblade" business model. The antennas sell for 2-3 thousand dollars each and up to three can be used in each procedure. THEY ARE SINGLE USE. DISPOSABLE.

    Simple math tells you that if Terumo places 100 MicroThermX systems and sells just 20 antennas a month to each unit holder, then there will be 4-5 million dollars in sales EVERY MONTH.

    100 x 20 x $2,000 = $4,000,000 a month and that's just a TINY example...... it will grow to significantly more!

    Anyone buying a MicroThermX will want to put it to use and keep it in use. They will not buy one and only do "a few" procedures in a month. They will do MANY MANY MANY, to recoup the investment and MAKE MONEY. Medicine is a business.

    For God's sake do the math and see the numbers. Microwave ablation is overtaking RFA as the number one method for tumor ablation due to it's superiority and efficacy and safety on nearly all counts. ALL studies show this.

    Don't believe the lies printed on these message boards.

    L@@K for yourselves at the evidence, and call the company !!!!!!!!!!

    AND I HAVE NOT EVEN TOUCHED ON THE HYPERTHERMIA BUSINESS and all the contracts in place in ASIA!

  • Reply to

    Nice jump on just 34000 shares .....

    by grleroy Oct 21, 2014 4:00 PM
    canstic1 canstic1 Oct 21, 2014 4:43 PM Flag

    No stock for sale ....big news is coming...go back and re-read my previous posts...

  • Reply to

    longs

    by cansticthewomanofthelosersbsdm Oct 20, 2014 1:43 PM
    canstic1 canstic1 Oct 20, 2014 2:51 PM Flag

    News is coming....big news...

  • Reply to

    You can't get mad because they suck at what they do

    by crease24 Oct 20, 2014 10:27 AM
    canstic1 canstic1 Oct 20, 2014 2:48 PM Flag

    Once you see the size of the sales revenues coming in you will know that there will be no more need for capital raising, at least not by sell stock....

  • Reply to

    You can't get mad because they suck at what they do

    by crease24 Oct 20, 2014 10:27 AM
    canstic1 canstic1 Oct 20, 2014 12:35 PM Flag

    Sigh. No longer a viable business? You are nothing but a simpleton stock basher. The business at BSDM is THRIVING. Sales are increasing daily. Distribution networks are expanding. Unsolicited multi-billion dollar companies are competing for distribution deals for the MicroThermX, Asia is about to be opened WIDE for hyperthermia AND MicroThermX, Terumo is expanding into the final 50 countries and on the way to creating 30 teaching centers around the globe for the MicroThermX. And so on and so on and so on.

    You are a nobody who has never built a business let alone a medical business. The stock price is in no way reflective of what is happening daily at BSDM. They have 10 million dollars in cash and a burn rate of just 500,000 dollars a month. They are taking IN cash as sales are made. Probably have roughly 2 years of operating capital. Sales will EXPLODE well before they run out of cash.

    The " business" at BSDM has never been MORE VIABLE than it is today. Never. And you can buy the company at bargain basement prices. We have seen this many times before with other medical device companies given up for lost because investors can't see what is going on. Laserscope, ISRG, etc. have been mentioned here before along with a slew of others that were all trading in the pennies before the sales traction started and they exploded 1000's of percentages higher. Sell and go home if you have given up.

    The rest of you will be well rewarded in Fiscal 2015, the year we are currently in right now. There will be an year end report coming in the first week of November folowed by a conference call and all will be made crystal clear for those of you with thick skulls.

    Now get in there and BUY Mortimer, BUY!

  • canstic1 canstic1 Oct 19, 2014 7:48 PM Flag

    The deal with Orientech China, which is now approved by the China FDA is for sale of eight (8) BSD-200's per year at a MINIMUM. They will most likely buy more. The deal to Taiwan calls for sale of 5 units per year MINIMUM, and they will most likely buy more. South Korea has a deal for anothe 5 per year, but the approval in SK is still pending.

    We are now in the Q1 of fiscal year 2015 for BSDM. AT A MINIMUM, for this new fiscal year there will be 13 BSD-2000's sold, guaranteed to China and Taiwan. BSDM has never sold 13 bsd-200's in a single year , ever!

    These machines sell for $500,000 to over $1 million depending on how they are outfitted. That means at a minimum, and I stress MINIMUM, there will be $6.5 million in sales of BSD-2000's in fiscal year 2015.

    ADD in the sales of MicroThermX and replaceable antennas, and the MINIMUM sales I can possibly see occuring in fiscal 2015 is at least $10 million. BSDM has never had $10,000,000 in sales EVER

    And the stock is 50 cents? The historical low?

    What about GROWTH IN SALES? Factor that in? More likely BSDM will be pushing 20 million in sales than 10 million in fiscal 2015.

    THINK PEOPLE. You are being handed a golden opportunity. Don't blow it.

  • canstic1 canstic1 Oct 19, 2014 7:48 PM Flag

    There is indeed a multi year agreement in place with Terumo, a multi billion dollar medical device distributor. There is a "secrecy clause" for lack of a better word, which prohibits BSDM from disclosing terms of the agreement, or specific sales numbers. This is in place in order to allow Terumo an opportunity to ramp up sales without giving away any strategic information to the competition.

    Terumo has invested substantial amounts into the launch of MicrothermX AROUND THE GLOBE INTO 100 COUNTRIES. Probably millions, as was in their agreement. They are presenting at all the conferences and showing/training on the product.

    Sales are being made virtually everyday, either of new systems or from re-orders of the replaceable single use antennas. All this information is in the recent press releases, and it's all TRUE.

    Korn Ferry, a very well know high end executive search firm has presented the board with several candidates for the CEO position and they are all being interviewed and vetted.

    Business continues unimpeded at BSDM, and Butch Wolcott is still very much leading the company, and will remain on the Board after his replacement is found. His departure is in no way linked to performance at the company. It was pointed out that he was instrumental in securing the Terumo agreement and remains instrumental for future agreements CURRENTLY being negotiated.

    The business continues, expansion continues, there is plenty of cash in the bank, the company is operating on all cylinders.

    Anything else said here or on any other message board is a blatant lie, most likely spread by the competition in an attempt to strengthen their position at the bargaining table, with regards to alliances now being discussed.

    Call or email the company and they will address your questions directly.

    Terumo will never allow BSDM to go under or be sold outright without their approval. They have an enormous stake in them due to the fact that they have invested millions of dollars and thousands of man hours to educate and teach the market about MicroThermX such that they can SELL SELL SELL for years to come.

    MicrothermX has a cash cow "razorblade" business model. The antennas sell for 2-3 thousand dollars each and up to three can be used in each procedure. THEY ARE SINGLE USE. DISPOSABLE.

    Simple math tells you that if Terumo places 100 MicroThermX systems and sells just 20 antennas a month to each unit holder, then there will be 4-5 million dollars in sales EVERY MONTH.

    100 x 20 x $2,000 = $4,000,000 a month and that's just a TINY example...... it will grow to significantly more!

    Anyone buying a MicroThermX will want to put it to use and keep it in use. They will not buy one and only do "a few" procedures in a month. They will do MANY MANY MANY, to recoup the investment and MAKE MONEY. Medicine is a business.

    For God's sake do the math and see the numbers. Microwave ablation is overtaking RFA as the number one method for tumor ablation due to it's superiority and efficacy and safety on nearly all counts. ALL studies show this.

    Don't believe the lies printed on these message boards.

    L@@K for yourselves at the evidence, and call the company !!!!!!!!!!

    AND I HAVE NOT EVEN TOUCHED ON THE HYPERTHERMIA BUSINESS and all the contracts in place in ASIA!

  • canstic1 canstic1 Oct 17, 2014 1:39 AM Flag

    The deal with Orientech China, which is now approved by the China FDA is for sale of eight (8) BSD-200's per year at a MINIMUM. They will most likely buy more. The deal to Taiwan calls for sale of 5 units per year MINIMUM, and they will most likely buy more. South Korea has a deal for anothe 5 per year, but the approval in SK is still pending.

    We are now in the Q1 of fiscal year 2015 for BSDM. AT A MINIMUM, for this new fiscal year there will be 13 BSD-2000's sold, guaranteed to China and Taiwan. BSDM has never sold 13 bsd-200's in a single year , ever!

    These machines sell for $500,000 to over $1 million depending on how they are outfitted. That means at a minimum, and I stress MINIMUM, there will be $6.5 million in sales of BSD-2000's in fiscal year 2015.

    ADD in the sales of MicroThermX and replaceable antennas, and the MINIMUM sales I can possibly see occuring in fiscal 2015 is at least $10 million. BSDM has never had $10,000,000 in sales EVER

    And the stock is 50 cents? The historical low?

    What about GROWTH IN SALES? Factor that in? More likely BSDM will be pushing 20 million in sales than 10 million in fiscal 2015.

    THINK PEOPLE. You are being handed a golden opportunity. Don't blow it.

SBLK
10.33-0.28(-2.64%)Oct 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.